Recent Updates
Recently added Catalysts
EBS Positive Sentiment

Emergent BioSolutions Participates in Upcoming International Preparedness Conferences

Key Takeaway: Emergent BioSolutions Inc. will participate in several international preparedness conferences, including the London Defence Conference and the Global Health Security Conference. The company's teams aim to collaborate with government and industry leaders to enhance global health security. Emergent specializes in medical countermeasures to protect against various health threats.
Price reaction · baseline $8.38 (2026-04-01 close) · hit after-hours · 1 other EBS headline(s) in the window, move may be shared
day 0 close
-1.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Emergent BioSolutions is actively participating in key international conferences.
  • The company emphasizes its commitment to global health security.
  • Engagement with government and industry leaders is a priority.
  • Emergent's products support preparedness against critical health threats.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+70%
120-day peak, hindsight
Typical move
8%
average across 2 past catalysts
Lead asset
FLU-IGIV
Phase 2 · Influenza A H3N2

Full Press Release Details

GAITHERSBURG, Md., April 02, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a global life sciences leader with biodefense and medical countermeasures products, announced today that members of its products business, medical affairs, government and public affairs teams will participate in the following international preparedness conferences:
• London Defence Conference, April 10-11, London, United Kingdom
• CBRN Research & Innovation Conference, May 19-21, Arcachon, France
• Global Health Security Conference, June 9-12, Kuala Lumpur, Malaysia
• BIO International Convention, June 20-22, San Diego, California, United States
“As the world navigates an increasingly complex health threat landscape, Emergent is committed to working with governments to help protect regional and global security,” said Paul Williams, senior vice president, head of products business, global government and public affairs. “We look forward to engaging with government and industry leaders to discuss how together we can strengthen preparedness and help protect and save lives.”
Emergent specializes in developing, manufacturing and delivering medical countermeasures to governments around the world for security and preparedness. These products support emergency response preparedness and help protect the public from critical threats like smallpox, anthrax, botulism and Ebola. Learn more about how we help protect people worldwide from biological threats atemergentbiosolutions.com/biothreats.
AboutEmergent BioSolutionsAt Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit ourwebsiteand follow us onLinkedIn,X,Instagram,Apple PodcastsandSpotify.

Investor Contact:Richard S. LindahlExecutive Vice President, CFOlindahlr@ebsi.com

Media Contact:Assal HellmerVice President, Communicationsmediarelations@ebsi.com

Frequently Asked Questions

What conferences will Emergent BioSolutions attend?

Emergent BioSolutions will attend the London Defence Conference, CBRN Research & Innovation Conference, Global Health Security Conference, and BIO International Convention.

What is the focus of Emergent's participation?

Emergent aims to collaborate with government and industry leaders to strengthen global health security.

What products does Emergent BioSolutions develop?

Emergent specializes in medical countermeasures for threats like smallpox, anthrax, and Ebola.

How long has Emergent been in operation?

Emergent BioSolutions has been working for over 25 years to protect public health.

Last updated: Apr 2, 2026